Yumed News

From June 19 to June 21, 2023, the 21st World Pharmaceutical Raw Materials China Exhibition will gather and set sail at the Shanghai New International Expo Center (Pudong), aiming to promote industry exchange and cooperation, promote common prosperity and development, and build a high-quality trade platform for pharmaceutical enterprises to link global markets through competition, cooperation, and win-win cooperation

yumed Pharmaceutical will bring the company's pharmaceutical intermediates and API products to the grand event to discuss the development path of the industry with new and old friends. We cordially invite you to visit N4G39 and learn about our latest products and technologies. At the same time, our sales personnel will also provide you with professional product introductions and problem-solving on-site

The specific exhibition information is as follows:

Address: Shanghai New International Expo Center (No. 2345 Longyang Road, Pudong New Area, Shanghai)

Time: June 19th to June 21st, 2023

Our location: N4G39

About yumed Pharmaceutical

Suzhou yumed Pharmaceutical Technology Co., Ltd. (referred to as "yumed Pharmaceutical"), established in 2021, is a CDMO supplier that specializes in providing one-stop services for small molecule drug customers from route development to commercialization, including research and development, production, and registration application. Its business covers laboratory customization; Process development; Intermediate and API pilot production, product sales, commercial production, etc

yumed Pharmaceutical actively promotes the construction of an innovative talent team, with over 50 employees, over 50% of whom hold graduate degrees or above. The core R&D management team members have an average of over 10 years of experience in the pharmaceutical industry, and have vertical integration capabilities in the development and production of small molecule drugs. They are skilled in customized synthesis, process development, raw material production, and commercial production of intermediates for various types of small molecule drugs

yumed Pharmaceutical adheres to technological innovation driven enterprise development, with an existing research and development site area of over 7500 square meters and a production base area of over 150 acres. It is equipped with various pharmaceutical production equipment such as microchannel reactors, glove boxes, LC-MS, HPLC, and hundreds of large-scale analytical and detection precision instruments. It has the ability to research and develop CDMO from pharmaceutical intermediates to raw materials, as well as a research and development process and production quality management system that meets international standards, Can help customers improve R&D production efficiency and accelerate the drug launch process

yumed Pharmaceutical is headquartered in Suzhou, Jiangsu, with Suzhou yumedsheng New Drug Development Co., Ltd. (Suzhou R&D Center and CDMO Factory), Wuhan yumed New Drug Technology Development Co., Ltd. (Wuhan R&D Center), Hunan Runxing Pharmaceutical Co., Ltd. (Hunan GMP Factory), and Suzhou Yamei Pharmaceutical Technology Co., Ltd. (Business Center)